Invention Grant
- Patent Title: PCSK9 peptide combination vaccine and method of use
-
Application No.: US14921485Application Date: 2015-10-23
-
Publication No.: US09669079B2Publication Date: 2017-06-06
- Inventor: Sylvia Brunner , Gergana Galabova , Bettina Wanko , Markus Windwarder , Gabriele Winsauer , Guenther Staffler , Claudia Juno
- Applicant: AFFIRIS AG
- Applicant Address: AT Vienna
- Assignee: AFFIRIS AG
- Current Assignee: AFFIRIS AG
- Current Assignee Address: AT Vienna
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: EP11181090 20110913
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/39 ; C12N9/64 ; C07K16/40 ; A61K39/385
Abstract:
The present invention relates to a immunogen comprising at least two fragments of Proprotein convertase subtilisin/kexin type 9 (PCSK9), wherein at least two fragments comprise at least 8 consecutive amino acid residues of amino acid residues 150 to 170 and/or 205 to 225 of PCSK9 (SEQ ID NO:9).
Public/Granted literature
- US20160106822A1 PCSK9 PEPTIDE COMBINATION VACCINE AND METHOD OF USE Public/Granted day:2016-04-21
Information query
